Plexus Venus
Natural health product licensed in Canada
- Licence holder
- Plexus Canada Limited Partnership dba Plexus Worldwide
- NPN or DIN-HM
- 80112042
- Status
- Inactive licence
- Licence date
- 12 August 2021
- Revision date
- 20 August 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 500 mg | 100 mg | Not calculated |
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 150 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 150 mg | Not calculated |
| Crocus sativus Source : Stigmates Extract : Matériel brut frais Extraction ratio : 5:1 Dry plant equivalent : 150 mg Potency : 2 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde | 30 mg | Not calculated |
| Withania somnifera Source : Feuille Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 625 mg Potency : 10 % Withanolide glycosides | 125 mg | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 625 mg Potency : 10 % Withanolide glycosides | 125 mg | Not calculated |
| Crocus sativus Source : Stigmates Potency : 3 % Crocin | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 0.05 % Withaferin A | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 0.05 % Withaferin A | Not specified | Not calculated |
Non-medicinal ingredients
Maltodextrine, farine de riz, Hypromellose, Triglycérides à chaîne moyenne, Dioxyde de silicium, Phosphate de dicalcium dihydraté
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities. Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. Source of /Provides antioxidants. Source of /Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effects of/the oxidative damage caused by/cell damage caused by) free radicals. (Provides) An antioxidants. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress. Helps to temporarily relieve symptoms of stress. Helps to support/promote/maintain (healthy) mood balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80112042
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.